Chest pain - A strong predictor of adverse cardiac events following percutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISTENT])

Mark A. Robbins, Steven P. Marso, Kathy Wolski, John Peterson, A. Michael Lincoff, Sorin Brener

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Chest pain - A strong predictor of adverse cardiac events following percutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISTENT])'. Together they form a unique fingerprint.